Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Health and Healthcare

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

256 Articles

Lee Jackson | May 11, 2020 at 7:24 AM EDT

5 Top Health Care Stocks to Buy Now on the Goldman Sachs Conviction List

These are five of the best stocks in a sector that has been humming along in what has been a…

Jon C. Ogg | Apr 30, 2020 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify, Tesla and More

Thursday's top analyst upgrades and downgrades included Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify and Tesla.

Jon C. Ogg | Apr 28, 2020 at 9:02 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, Cognex, Disney, J&J, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero and More

Tuesday's top analyst upgrades and downgrades included AT&T, Cognex, Johnson & Johnson, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero…

Lee Jackson | Apr 27, 2020 at 7:15 AM EDT

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies…

Jon C. Ogg | Jan 30, 2020 at 5:35 PM EST

7 Major After-Hours Movers on Thursday

Companies like IBM, Amazon, Western Digital and EA all posted big moves, some far more than what was expected, in…

Chris Lange | Jan 23, 2020 at 1:35 PM EST

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.

Jon C. Ogg | Dec 16, 2019 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Adobe, Amgen, BofA, Broadcom, CME, Goldman Sachs, Micron, PepsiCo, UnitedHealth, Urban Outfitters, Vertex and More

Monday's top analyst upgrades, downgrades and initiations included Adobe, Amgen, Bank of America, Broadcom, CME, Goldman Sachs, Micron Technology, PepsiCo,…

Jon C. Ogg | Nov 12, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva…

Jon C. Ogg | Oct 22, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Dropbox, EA, Halliburton, Intuit, Juniper Networks, ProLogis, Silicon Motion, Taiwan Semi, Textron, Vertex and More

Tuesday's the top analyst upgrades, downgrades and initiations included Dropbox, Electronic Arts, Halliburton, Intuit, Juniper Networks, ProLogis, Silicon Motion, Taiwan…

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Jon C. Ogg | Oct 18, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap,…

Jon C. Ogg | Oct 17, 2019 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences,…

Lee Jackson | Sep 30, 2019 at 7:55 AM EDT

Jefferies Has 4 Red-Hot Growth Stocks to Buy With Huge Upside Potential

These four stocks make good sense now, as they all have outstanding upside potential and are among the Jefferies top…

Jon C. Ogg | Sep 3, 2019 at 12:20 PM EDT

Vertex Scores Key Analyst Upgrade on Top of Making an Acquisition

On top of the company announcing an acquisition on Tuesday, Vertex has seen a substantial analyst upgrade from Goldman Sachs.

Trey Thoelcke | Aug 26, 2019 at 11:55 AM EDT

Vertex Pharmaceuticals and Other Biotech Stocks With Recent Golden Crosses

Here are three biotech stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross,…

1 … 3 4 5 6 7 … 18

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

5 Top Health Care Stocks to Buy Now on the Goldman Sachs Conviction List

Top Analyst Upgrades and Downgrades: Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify, Tesla and More

Top Analyst Upgrades and Downgrades: AT&T, Cognex, Disney, J&J, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero and More

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

7 Major After-Hours Movers on Thursday

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Top Analyst Upgrades and Downgrades: Adobe, Amgen, BofA, Broadcom, CME, Goldman Sachs, Micron, PepsiCo, UnitedHealth, Urban Outfitters, Vertex and More

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Top Analyst Upgrades and Downgrades: Dropbox, EA, Halliburton, Intuit, Juniper Networks, ProLogis, Silicon Motion, Taiwan Semi, Textron, Vertex and More

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Jefferies Has 4 Red-Hot Growth Stocks to Buy With Huge Upside Potential

Vertex Scores Key Analyst Upgrade on Top of Making an Acquisition

Vertex Pharmaceuticals and Other Biotech Stocks With Recent Golden Crosses

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Missed CRWD’s Rally? This ETF Paid 29% in the Same Six Months

QQQI Holders Left $7.63 Per Share on the Table While Chasing Monthly Dividends

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.

Missed CRWD’s Rally? This ETF Paid 29% in the Same Six Months

QQQI Holders Left $7.63 Per Share on the Table While Chasing Monthly Dividends

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

5 Top Health Care Stocks to Buy Now on the Goldman Sachs Conviction List

Top Analyst Upgrades and Downgrades: Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify, Tesla and More

Top Analyst Upgrades and Downgrades: AT&T, Cognex, Disney, J&J, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero and More

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

7 Major After-Hours Movers on Thursday

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Top Analyst Upgrades and Downgrades: Adobe, Amgen, BofA, Broadcom, CME, Goldman Sachs, Micron, PepsiCo, UnitedHealth, Urban Outfitters, Vertex and More

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Top Analyst Upgrades and Downgrades: Dropbox, EA, Halliburton, Intuit, Juniper Networks, ProLogis, Silicon Motion, Taiwan Semi, Textron, Vertex and More

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Jefferies Has 4 Red-Hot Growth Stocks to Buy With Huge Upside Potential

Vertex Scores Key Analyst Upgrade on Top of Making an Acquisition

Vertex Pharmaceuticals and Other Biotech Stocks With Recent Golden Crosses

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Missed CRWD’s Rally? This ETF Paid 29% in the Same Six Months

QQQI Holders Left $7.63 Per Share on the Table While Chasing Monthly Dividends

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

Featured Reads

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.